These data suggest that β-AR and LPA3 mediate distinct effectors and, in support of this, the present study provides experimental evidence for LPA-LPA3 signaling being distinct from ISO-β-AR-mediated myocardial hypertrophy. This evidence concerns the gene LPAR3 and cardiac hypertrophy.